Suicide gene therapy of hepatocellular carcinoma and delivery procedure and route of therapeutic gene in vivo

Hepatobiliary and Pancreatic Diseases International

Volumn 1, Issue 3, 2002, Pages 373-377

  Sun, Xiao Yi ^a   Wu, Zai De ^a   Hu, Jun Bo ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Bystander effect; Epstein Barr virus; Gene therapy; Gene transfer in vivo; Hepatocellular carcinoma; Tk gene

Indexed keywords

ACICLOVIR; COMPLEMENTARY DNA; GANCICLOVIR; INTERLEUKIN 2; LIPOFECTIN; LIPOSOME; NAKED DNA; PLASMID DNA; PLASMID VECTOR; THYMIDINE KINASE; VIRUS VECTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ARTIFICIAL EMBOLISM; BYSTANDER EFFECT; CANCER CELL CULTURE; COLORIMETRY; COMPLEX FORMATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG SENSITIVITY; EPSTEIN BARR VIRUS; EXPRESSION VECTOR; GENE EXPRESSION; GENETIC TRANSFECTION; HEPATIC ARTERY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; LIVER CELL CARCINOMA; NONHUMAN; PLASMID; RAT; SUICIDE GENE THERAPY; VIRAL GENE DELIVERY SYSTEM;

ACYCLOVIR; ANIMALS; ANTIVIRAL AGENTS; CARCINOMA, HEPATOCELLULAR; CELL DEATH; CELL LINE, TUMOR; DOSE-RESPONSE RELATIONSHIP, DRUG; GANCICLOVIR; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENES, TRANSGENIC, SUICIDE; GENETIC VECTORS; HERPESVIRUS 4, HUMAN; HUMANS; LIVER NEOPLASMS; PROTEIN-TYROSINE KINASES; RATS; RATS, WISTAR; SIMPLEXVIRUS;

EID: 0037635215     PISSN: 14993872     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. Moolten FL. Tumor chemosensitivity conferred by inserted herpes thymidine kinase gene: paradigm for a prospective cancer control strategy. Cancer Res 1986; 46:5276-5281.
2. Kuriyama S, Nakatani T, Masui K, et al. Bystander effect caused by suicide gene expression indicates the feasibility of gene therapy for hepatocellular carcinoma. Hepatology 1995;22:1838-1846.
3. Heller RA, Song K, Villaret D, et al. Amplified expression of tumor necrosis factor receptor in cells transfected with Epstein-Barr virus shuttle vector cDNA libraries. Biol Chem 1990;265:5708-5717.
4. Freeman SM, Abboud CN, Whartenby KA, et al. The "bystander effect": tumor regression when a fraction of the tumor mass is genetically modified. Cancer Res 1993;53:5274-5283.
5. Huber BE, Richards CA, Krenitsky TA. Retroviral-mediated gene therapy for the treatment of hepatocellular carcinoma: an innovative approach for cancer therapy. Proc Natl Acad Sci USA 1991;88:8039-8043.
6. Kanai F, Shiratori Y, Yoshida Y, et al. Gene therapy for alpha-fetoprotein-producing human hepatoma cells by adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene. Hepatology 1996;23:1359-1368.